These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37531955)

  • 1. Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates.
    He W; Ou T; Skamangas N; Bailey CC; Bronkema N; Guo Y; Yin Y; Kobzarenko V; Zhang X; Pan A; Liu X; Xu J; Zhang L; Allwardt AE; Mitra D; Quinlan B; Sanders RW; Choe H; Farzan M
    Immunity; 2023 Oct; 56(10):2408-2424.e6. PubMed ID: 37531955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.
    Bibollet-Ruche F; Russell RM; Ding W; Liu W; Li Y; Wagh K; Wrapp D; Habib R; Skelly AN; Roark RS; Sherrill-Mix S; Wang S; Rando J; Lindemuth E; Cruickshank K; Park Y; Baum R; Carey JW; Connell AJ; Li H; Giorgi EE; Song GS; Ding S; Finzi A; Newman A; Hernandez GE; Machiele E; Cain DW; Mansouri K; Lewis MG; Montefiori DC; Wiehe KJ; Alam SM; Teng IT; Kwong PD; Andrabi R; Verkoczy L; Burton DR; Korber BT; Saunders KO; Haynes BF; Edwards RJ; Shaw GM; Hahn BH
    mBio; 2023 Feb; 14(1):e0337022. PubMed ID: 36629414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.
    Schorcht A; van den Kerkhof TLGM; Cottrell CA; Allen JD; Torres JL; Behrens AJ; Schermer EE; Burger JA; de Taeye SW; Torrents de la Peña A; Bontjer I; Gumbs S; Ozorowski G; LaBranche CC; de Val N; Yasmeen A; Klasse PJ; Montefiori DC; Moore JP; Schuitemaker H; Crispin M; van Gils MJ; Ward AB; Sanders RW
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.
    Willis JR; Berndsen ZT; Ma KM; Steichen JM; Schiffner T; Landais E; Liguori A; Kalyuzhniy O; Allen JD; Baboo S; Omorodion O; Diedrich JK; Hu X; Georgeson E; Phelps N; Eskandarzadeh S; Groschel B; Kubitz M; Adachi Y; Mullin TM; Alavi NB; Falcone S; Himansu S; Carfi A; Wilson IA; Yates JR; Paulson JC; Crispin M; Ward AB; Schief WR
    Immunity; 2022 Nov; 55(11):2149-2167.e9. PubMed ID: 36179689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.
    Voss JE; Andrabi R; McCoy LE; de Val N; Fuller RP; Messmer T; Su CY; Sok D; Khan SN; Garces F; Pritchard LK; Wyatt RT; Ward AB; Crispin M; Wilson IA; Burton DR
    Cell Rep; 2017 Oct; 21(1):222-235. PubMed ID: 28978475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
    van Schooten J; van Haaren MM; Li H; McCoy LE; Havenar-Daughton C; Cottrell CA; Burger JA; van der Woude P; Helgers LC; Tomris I; Labranche CC; Montefiori DC; Ward AB; Burton DR; Moore JP; Sanders RW; Crotty S; Shaw GM; van Gils MJ
    PLoS Pathog; 2021 Aug; 17(8):e1009736. PubMed ID: 34432859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire.
    Ou T; He W; Quinlan BD; Guo Y; Tran MH; Karunadharma P; Park H; Davis-Gardner ME; Yin Y; Zhang X; Wang H; Zhong G; Farzan M
    Mol Ther; 2022 Jan; 30(1):184-197. PubMed ID: 34740791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.
    Williams WB; Wiehe K; Saunders KO; Haynes BF
    J Int AIDS Soc; 2021 Nov; 24 Suppl 7(Suppl 7):e25831. PubMed ID: 34806332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.
    van Haaren MM; McCoy LE; Torres JL; Lee W; Cottrell CA; Copps JL; van der Woude P; Yasmeen A; de Taeye SW; Torrents de la Peña A; Moore JP; Burton DR; Klasse PJ; Ward AB; Sanders RW; van Gils MJ
    J Virol; 2021 Aug; 95(17):e0009421. PubMed ID: 34076487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
    Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
    J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
    Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro affinity maturation of broader and more-potent variants of the HIV-1-neutralizing antibody CAP256-VRC26.25.
    Yin Y; Quinlan BD; Ou T; Guo Y; He W; Farzan M
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34261793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice.
    Melzi E; Willis JR; Ma KM; Lin YC; Kratochvil S; Berndsen ZT; Landais EA; Kalyuzhniy O; Nair U; Warner J; Steichen JM; Kalyuzhniy A; Le A; Pecetta S; Perez M; Kirsch K; Weldon SR; Falcone S; Himansu S; Carfi A; Sok D; Ward AB; Schief WR; Batista FD
    Immunity; 2022 Nov; 55(11):2168-2186.e6. PubMed ID: 36179690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design.
    Andrabi R; Voss JE; Liang CH; Briney B; McCoy LE; Wu CY; Wong CH; Poignard P; Burton DR
    Immunity; 2015 Nov; 43(5):959-73. PubMed ID: 26588781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers.
    de Taeye SW; Go EP; Sliepen K; de la Peña AT; Badal K; Medina-Ramírez M; Lee WH; Desaire H; Wilson IA; Moore JP; Ward AB; Sanders RW
    J Biol Chem; 2019 Apr; 294(14):5616-5631. PubMed ID: 30728245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
    LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC
    PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV B Cell lines as candidate vaccine biosensors.
    Ota T; Doyle-Cooper C; Cooper AB; Huber M; Falkowska E; Doores KJ; Hangartner L; Le K; Sok D; Jardine J; Lifson J; Wu X; Mascola JR; Poignard P; Binley JM; Chakrabarti BK; Schief WR; Wyatt RT; Burton DR; Nemazee D
    J Immunol; 2012 Nov; 189(10):4816-24. PubMed ID: 23066156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.